The article describes the mechanisms of action, pharmacokinetics, and pharmacodynamics
of aspirin, dipyridamole, cilostazol, the thienopyridines, and the glycoprotein IIb/IIIa …

Preeclampsia is a common complication of pregnancy associated with high maternal
morbidity and mortality and intrauterine fetal growth restriction. There is extensive evidence …

Preeclampsia is characterized by hypertension and de novo proteinuria after 20 weeks of
pregnancy. It is the leading cause of perinatal morbidity and mortality in the developed …

Preeclampsia (PE) is known to represent an exaggerated maternal inflammatory response
to pregnancy. Lipoxin A4 (LXA4), considered as an endogenous stop signal in inflammation …

AIMS: Preeclampsia (PE), fetal growth restriction (FGR) and gestational diabetes mellitus
(GDM) are major pregnancy complications affecting maternal and fetal health. The placenta …

AIM: The clinical guidelines reported by the French-Speaking Diabetes Society (Société
francophone du diabète) include updated recommendations for preconceptual planning and …

The decision of when to deliver a patient for medical or obstetric complication directly affects
the neonatal outcome. When the fetus is in danger due to suspected utero-placental …

Thromboembolism is an infrequent, yet serious cause of both maternal and fetal morbidity
and death during pregnancy and the puerperium. Antithrombotic treatment and prophylaxis …

Increased levels of pro-inflammatory factors, markers of oxidative stress and insulin
resistance during pregnancy have been associated with the development of pre-eclampsia …

TORREGROSA, José V. et al. Tratamiento eficaz de la arteriolopatía urémica calcificante
con bifosfonatos. Nefrología (Madr.)[online]. 2012, vol. 32, n. 3, pp. 329-334. ISSN 0211 …